Focus on Survival<br />By Rev Shark<br />RealMoney.com Contributor<br />11/11/2008 8:15 AM EST <br /><br />There are no winners, only survivors. <br />-- Frank Gifford<br /><br />To succeed in this market is to survive. That means keeping your capital safe and losses limited. Unfortunately in the world of Wall Street, survival is not viewed the same way. Most Wall Street professionals try to find a way to stay heavily invested such that they will have less losses than the overall market. <br /><br />Losing less money is considered a big success on Wall Street. In the world of fund management, relative outperformance vs. a benchmark is the focus, but any individual who is struggling to only lose 30% or so vs. the 37% that the S&P 500 has lost is going to barely survive. <br /><br />The key here is to forget the Wall Street model of investment management and to focus zealously on protecting your precious capital. Your job is not to stay invested in a lousy market or to try to guess when the bottom might come. Your job is to preserve your cash so you can build up your gains when the odds are in your favor. <br /><br />Focus on keeping your account as close to all-time highs as possible. The most destructive thing an investor can do is rack up big losses that you need to recover before you can have your account back in the black. Making up losses is hugely unproductive. If you lose 40% of your capital, like the Nasdaq has done so far this year, then you need a gain of 67% just to get back to even. That is why you just sit and buy and hope. <br /><br />This is one of the worst markets in our lifetimes, and we have to stay focused on surviving as best we can. The folks on Wall Street are already buried in losses, and they are going to keep pushing us to do what they have done -- ride a bunch of stocks down as they constantly try to predict a major turning point. <br /><br />A turning point will come, and we will join the party. We'll probably be late as we await confirmation of a tradable bottom, but it won't matter one bit because we won't have to make up a 40% or 50% loss like the serial bottom-callers. Stay patient and focus on capital preservation. <br /><br />We have a weak open on the way and lots of negative news out there. Technically, the October lows are the key levels to watch. There is no way we can trust this market right now with this deteriorating technical pattern and challenge of support levels on the horizon. <br /><br />Stay tough, stay patient and don't risk your capital on hope. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: TMA +40.9%, TA +13.0% (light volume), VOD +10.4%, ESC +5.4%, ASEI +4.6% (light volume)... Other news: OPTR +93.5% (reports "positive data" from its North American phase 3 CDI study of OPT-80; also upgraded to Outperform at Baird), LNET +24.4% (Mark Cuban files 13D reporting 9.9% stake; may seek talks with LNET), ASTI +6.4% (Ascent Solar and TurtleEnergy sign cooperation agreement), WYNN +2.5% (will replace ASH in the S&P 500), BUCY +1.8% (will replace DENTSPLY in the S&P MidCap 400), XRAY +1.2% (will replace HRC in the S&P 500), PPG +1.1% (Cramer makes positive comments on MadMoney), CHK +1.0% (announces Marcellus Shale joint venture and international unconventional natural gas exploration alliance with StatoilHydro).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: KFN -36.0% (also downgraded to Market Perform at Friedman Billings and downgraded to Sell at Citigroup), SIL -30.1%, FMCN -22.3% (also downgraded to Neutral from Positive at Susquehanna Financial, downgraded to Accumulate at ThinkEquity), USAP -12.0% (light volume), LVS -6.3%, CPSL -6.2%, TOL -4.4%, SBUX -3.2%... Select financial names showing continued weakness: GNW -13.6% (discloses that it is no longer eligible to sell commercial paper to the Commercial Paper Funding Facility; also Moody's downgrades Genworth senior debt to Baa1), HBC -6.5%, AIG -6.1% (estimates cut at Stifel), MS -2.5%, ING -2.5%, GS -2.3%, BAC -1.2%, C -1.0%... Select metals/mining stocks showing weakness with lower spot prices: AUY -4.7%, BHP -4.5%, RTP -4.1%, GFI -3.1%, GLD -1.7%... Select oil/gas names showing weakness with crude lower: BP -3.1%, RDS.A -2.8%, TOT -2.0%, XOM -1.7%... Other news: SGMO -57.8% (announces results from diabetic Neuropathy clinical trial SB-509-601; also downgraded to Sell from Buy at Piper Jaffray), TLEO -28.5% (delays quarterly financial report; announces re-evaluation of timing of revenue recognition; also downgraded to Perform at Oppenheimer), VPHM -8.5% (OPTR reported positive results for OPT-80 and reported only 13.3% of patients treated with OPT-80 experienced a recurrence vs. 24.0% for VPHM's Vancocin), AA -5.3% (to curtail additional 350,000 mtpy of aluminum production across its Global Smelting System; also downgraded to Market Perform at Friedman Billings), GOOG -2.7% (Google 4Q revenue forecast cut at Goldman on poor macro data- Bloomberg), AZN -1.6% (still checking for anything specific)... Analyst comments: TSN -11.4% (downgraded to Underweight at JPMorgan), PRU -8.7% (downgraded to Sell at Goldman - Bloomberg), HIG -5.8% (downgraded to Sell at Goldman - Bloomberg), ACAS -4.1% (downgraded to Mkt Perform from Outperform at William Blair and downgraded to Hold at BB&T).